Researchers have discovered some surprising insights about the process of axonal pruning. The findings could provide clues about the processes underlying some neurological disorders such as autism and schizophrenia.
Cinnamaldehyde and epicatechin, two compounds found in cinnamon, are showing promise in the fight against Alzheimer’s disease.
Bexarotene, an anti-cancer drug which is about to be tested in a clinical trial as a potential treatment for Alzheimer’s disease, fails to reduce amyloid plagues; according to researchers replicating the original study.
Using mouse models, researchers discover TSPO ligands can significantly decrease Alzheimer’s related symptoms and improve memory. The discovery could lead to preventative and new treatment options for Alzheimer’s disease.
A new study has pinpointed a catalytic trigger for the onset of Alzheimer’s disease. The findings could play a central role in the diagnostics and new drug development for neurodegenerative diseases.
According to new research, people who had skin cancer were almost 80% less likely to later develop Alzheimer’s disease.
Researchers have identified biomarkers for Alzheimer’s disease which accurately predict the development of the disease years prior to symptoms developing.
A drug developed by scientists at the Salk Institute for Biological Studies, known as J147, reverses memory deficits and slows Alzheimer’s disease in aged mice following short-term treatment.
Researchers have discovered a way in which the body can remove injured axons. They also identified a potential target for new drugs which could prevent the inappropriate loss of axons, as well as maintain nerve function.
Using a tiny dose of the leukemia drug nilotinib, researchers halt the accumulation of toxic proteins linked to Parkinson’s diseases in the brains of mice.